Part 1 — Interpretation

3. For the purposes of this Scheme, unless a contrary intention appears:

“Act” means the Australian Participants in British Nuclear Tests (Treatment) Act 2006.

“Approved Hospital Authority” means a hospital authority approved under section 94 of the National Health Act 1953 for the purposes of supplying Pharmaceutical Benefits;

“Approved Medical Practitioner” means a medical practitioner approved under section 92 of the National Health Act 1953 for the purposes of supplying Pharmaceutical Benefits;

“Authority Prescription Form” means the form approved under:

(i) subregulation 13(2) of the National Health (Pharmaceutical Benefits) Regulations; or

(ii) paragraph 14 of declaration No. PB 10 of 1993 made under subsection 85(2) of the National Health Act 1953;

“approved supplier” has the meaning given in Part VII of the National Health Act 1953;

“Commission” means the Repatriation Commission continued in existence by section 179 of the Veterans’ Entitlements Act 1986;

“Community Pharmacist” means:

(a) a registered pharmacist approved for the purposes of section 90 of the National Health Act 1953 in charge of a community pharmacy; or

(b) a registered pharmacist approved for the purposes of section 90 of the National Health Act 1953, being the manager of a registered Friendly Society Dispensary; or

(c) an Approved Hospital Authority; or

(d) an Approved Medical Practitioner;

“Department” means the Department of Veterans’ Affairs;

“Diagnostic Agents” means Agents intended to facilitate the determination of human disease and/or human physiological states;

“Drugs” or “Medicines” means “goods for therapeutic use” as defined for human use by the Therapeutic Goods Act 1989;

“Eligible Person” means a person eligible for treatment under the Act who, if one has been granted, holds a Repatriation Health Card - For Specific Conditions;

“Explanatory Notes” means the text entitled “Explanatory Notes” and the text entitled “RPBS Explanatory Notes” that is published in the document, Schedule of Pharmaceutical Benefits for Approved Pharmacists and Medical Practitioners, having the International Standard Serial Number 1037-3667, and dated 1 February 2002, to the extent that that text is not inconsistent with this Scheme;

[Note: see attachment for date changes. This note is not part of this Instrument]

“Medical Practitioner” has the same meaning as “medical practitioner” has in the Health Insurance Act 1973;

“PBS” means the Pharmaceutical Benefits Scheme authorised under the National Health Act 1953;